Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Sara Elena RebuzziMatteo BrunelliFrancesca GaluppiniValerio Gaetano VelloneAlessio SignoriFabio CatalanoAlessandra DamassiGabriele GaggeroPasquale RescignoMarco MaruzzoSara MerlerFrancesca VignaniAlessia CavoUmberto BassoMichele MilellaOlimpia PanepintoManlio MencoboniMarta SbaragliaAngelo Paolo Dei TosVeronica MurianniMalvina CremanteMiguel Angel Llaja ObispoMichele MaffezzoliGiuseppe Luigi BannaSebastiano ButiGiuseppe FornariniPublished in: Cancers (2023)
to nivolumab were identified. Further investigation with genomic analyses is planned.